Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study

ÇAPKIN, ERHAN; KARKUCAK, MURAT; COŞAR, ARİF; AK, Emel; KARACA, Adem; Gokmen, Ferhat; BUDAK, Bayram; TOSUN, Mehmet

doi:10.1111/1756-185x.12311

Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study

ÇAPKIN E., KARKUCAK M., COŞAR A. M., AK E., KARACA A., Gokmen F., ...Daha Fazla

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.18, sa.5, ss.548-552, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 5
Basım Tarihi: 2015
Doi Numarası: 10.1111/1756-185x.12311
Dergi Adı: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.548-552
Anahtar Kelimeler: alanine transaminase, ankylosing spondylitis, aspartate transaminase, disease activity, TNF inhibitors, AUTOIMMUNE HEPATITIS, RHEUMATOID-ARTHRITIS, NO RELAPSE, INFLIXIMAB, PATIENT, ETANERCEPT, TOXICITY, DISEASES
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

AimTo retrospectively investigate and compare the effects of tumor necrosis factor alpha inhibitors (TNFi) on hepatic enzymes in ankylosing spondylitis (AS) patients.